HRTXHeron Therapeutics, Inc.

$162M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$86M-2.6% YoY

Gross Profit

$40M46.7% margin

Operating Income

-$218M-252.3% margin

Net Income

-$221M-255.6% margin

EPS (Diluted)

$-2.24

Cash Flow

Operating Cash Flow

-$203M

Free Cash Flow

-$206M

Stock-Based Comp.

$47M

Balance Sheet

Total Assets

$306M

Total Liabilities

$228M

Stockholders' Equity

$78M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$89M	-2.6%
Gross Profit	$40M	$52M	-23.1%
Operating Income	-$218M	-$228M	+4.5%
Net Income	-$221M	-$227M	+2.9%

HRTX FY 2021 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena